Valeant Urges Fed. Circ. To Revive Antifungal Patent
The Patent Trial and Appeal Board invalidated a patent covering Valeant Pharmaceuticals' Jublia by expanding the definition of what the antifungal medication treated, the drugmaker told the Federal Circuit in a bid...To view the full article, register now.
Already a subscriber? Click here to view full article